Barclays’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
59,806
+30,595
| +105% | +$573K | ﹤0.01% | 2595 |
|
|
2025
Q1 | $526K | Sell |
29,211
-2,125
| -7% | -$38.3K | ﹤0.01% | 2821 |
|
|
2024
Q4 | $528K | Buy |
31,336
+3,991
| +15% | +$67.2K | ﹤0.01% | 3018 |
|
|
2024
Q3 | $442K | Buy |
27,345
+16,772
| +159% | +$271K | ﹤0.01% | 3066 |
|
|
2024
Q2 | $88K | Sell |
10,573
-4,484
| -30% | -$37.3K | ﹤0.01% | 3435 |
|
|
2024
Q1 | $223K | Sell |
15,057
-9,593
| -39% | -$142K | ﹤0.01% | 3285 |
|
|
2023
Q4 | $357K | Buy |
24,650
+20,485
| +492% | +$297K | ﹤0.01% | 3204 |
|
|
2023
Q3 | $45K | Sell |
4,165
-385
| -8% | -$4.16K | ﹤0.01% | 3645 |
|
|
2023
Q2 | $59K | Sell |
4,550
-5,321
| -54% | -$69K | ﹤0.01% | 3605 |
|
|
2023
Q1 | $131K | Buy |
9,871
+5,237
| +113% | +$69.5K | ﹤0.01% | 3388 |
|
|
2022
Q4 | $69K | Buy |
4,634
+3,902
| +533% | +$58.1K | ﹤0.01% | 3657 |
|
|
2022
Q3 | $9K | Sell |
732
-134
| -15% | -$1.65K | ﹤0.01% | 4236 |
|
|
2022
Q2 | $10K | Sell |
866
-3,987
| -82% | -$46K | ﹤0.01% | 4322 |
|
|
2022
Q1 | $145K | Sell |
4,853
-15,886
| -77% | -$475K | ﹤0.01% | 3497 |
|
|
2021
Q4 | $550K | Sell |
20,739
-14,985
| -42% | -$397K | ﹤0.01% | 2489 |
|
|
2021
Q3 | $1.3M | Buy |
35,724
+12,079
| +51% | +$439K | ﹤0.01% | 2107 |
|
|
2021
Q2 | $1.03M | Sell |
23,645
-18,747
| -44% | -$814K | ﹤0.01% | 2100 |
|
|
2021
Q1 | $1.45M | Buy |
42,392
+27,003
| +175% | +$924K | ﹤0.01% | 2091 |
|
|
2020
Q4 | $538K | Sell |
15,389
-3,041
| -17% | -$106K | ﹤0.01% | 2287 |
|
|
2020
Q3 | $441K | Sell |
18,430
-6,466
| -26% | -$155K | ﹤0.01% | 2371 |
|
|
2020
Q2 | $456K | Buy |
24,896
+4,050
| +19% | +$74.2K | ﹤0.01% | 2368 |
|
|
2020
Q1 | $325K | Sell |
20,846
-3,725
| -15% | -$58.1K | ﹤0.01% | 2335 |
|
|
2019
Q4 | $526K | Buy |
24,571
+3,621
| +17% | +$77.5K | ﹤0.01% | 2652 |
|
|
2019
Q3 | $392K | Buy |
20,950
+4,038
| +24% | +$75.6K | ﹤0.01% | 2734 |
|
|
2019
Q2 | $442K | Buy |
16,912
+6,101
| +56% | +$159K | ﹤0.01% | 2778 |
|
|
2019
Q1 | $278K | Buy |
10,811
+801
| +8% | +$20.6K | ﹤0.01% | 2885 |
|
|
2018
Q4 | $230K | Sell |
10,010
-16,946
| -63% | -$389K | ﹤0.01% | 2667 |
|
|
2018
Q3 | $866K | Sell |
26,956
-31,555
| -54% | -$1.01M | ﹤0.01% | 2340 |
|
|
2018
Q2 | $1.66M | Sell |
58,511
-34,156
| -37% | -$967K | ﹤0.01% | 1533 |
|
|
2018
Q1 | $3.28M | Buy |
92,667
+50,068
| +118% | +$1.77M | ﹤0.01% | 1095 |
|
|
2017
Q4 | $1.65M | Buy |
42,599
+25,769
| +153% | +$999K | ﹤0.01% | 1359 |
|
|
2017
Q3 | $427K | Buy |
16,830
+513
| +3% | +$13K | ﹤0.01% | 2005 |
|
|
2017
Q2 | $446K | Buy |
16,317
+13,113
| +409% | +$358K | ﹤0.01% | 1985 |
|
|
2017
Q1 | $106K | Sell |
3,204
-1,227
| -28% | -$40.6K | ﹤0.01% | 2804 |
|
|
2016
Q4 | $105K | Buy |
4,431
+664
| +18% | +$15.7K | ﹤0.01% | 2575 |
|
|
2016
Q3 | $137K | Sell |
3,767
-4,218
| -53% | -$153K | ﹤0.01% | 2312 |
|
|
2016
Q2 | $178K | Buy |
7,985
+3,268
| +69% | +$72.9K | ﹤0.01% | 2149 |
|
|
2016
Q1 | $94K | Buy |
4,717
+4,524
| +2,344% | +$90.2K | ﹤0.01% | 2340 |
|
|
2015
Q4 | $6K | Buy |
193
+69
| +56% | +$2.15K | ﹤0.01% | 2884 |
|
|
2015
Q3 | $2K | Sell |
124
-1,834
| -94% | -$29.6K | ﹤0.01% | 3541 |
|
|
2015
Q2 | $58K | Buy |
1,958
+977
| +100% | +$28.9K | ﹤0.01% | 2562 |
|
|
2015
Q1 | $29K | Sell |
981
-1,045
| -52% | -$30.9K | ﹤0.01% | 2973 |
|
|
2014
Q4 | $40K | Sell |
2,026
-2,777
| -58% | -$54.8K | ﹤0.01% | 3127 |
|
|
2014
Q3 | $48K | Buy |
4,803
+1,749
| +57% | +$17.5K | ﹤0.01% | 3020 |
|
|
2014
Q2 | $90K | Sell |
3,054
-2,180
| -42% | -$64.2K | ﹤0.01% | 2768 |
|
|
2014
Q1 | $156K | Buy |
5,234
+1,960
| +60% | +$58.4K | ﹤0.01% | 2521 |
|
|
2013
Q4 | $64K | Buy |
3,274
+148
| +5% | +$2.89K | ﹤0.01% | 3264 |
|
|
2013
Q3 | $94K | Sell |
3,126
-1,012
| -24% | -$30.4K | ﹤0.01% | 2967 |
|
|
2013
Q2 | $139K | Buy |
+4,138
| New | +$139K | ﹤0.01% | 2877 |
|